• Ranbaxy Launches Flotral Drug Treatment For Prostate Gland Enlargement BPH

    Ranbaxy Launches Flotral Drug Treatment For Prostate Gland Enlargement BPH

    Ranbaxy Laboratories Ltd has announced the launch of its benign prostatic hyperplasia (BPH) formulation, Flotral 10 mg or Alternative Tamsulosin formulation. It is a new uro-selective alpha1-blocker, prescription medicine that provides effective medical relief from signs and symptoms of BPH, a urological disorder. Flotral (alfuzosin), once a day medication, has been developed using the Novel

    READ MORE